←

ER GUIDE

Verbatim evidence guide · local formulary
16 protocols

EVIDENCE-BASED PEDIATRIC EMERGENCY MEDICINE PHARMACOTHERAPY GUIDE

Formulated Exclusively with the Palestinian Local Formulary (PALMEDICS). Every protocol below is the full original text — including in-ER regimens, discharge plans and red flags — with every brand linked to your local store (index). Enter weight once and all mg/kg doses auto-calculate. Also see: Adult emergency protocols (all modules) →

Asthma Croup Gastroenteritis Sepsis / Meningitis Pneumonia AOM / Sinusitis Seizures Anaphylaxis Fever / Pain Bronchiolitis UTI Strep Throat Otitis Externa Constipation Impetigo Quick Ref
All doses below are weight-based with worked examples — keep the child's weight handy.
1. PEDIATRIC ACUTE ASTHMA & STATUS ASTHMATICUS 1
EmergencyGINA · Cochrane▾

1. PEDIATRIC ACUTE ASTHMA & STATUS ASTHMATICUS

PRAM triage · dual nebulization · steroid within 1 hour · magnesium rescue

Background talk — PRAM, SABA & steroids

  • Clinical Presentation, Pathophysiology & Emergency Triage — Pathophysiologic Hallmarks: Bronchospasm, airway mucosal edema, inflammatory cell infiltration, and intraluminal mucus hypersecretion resulting in dynamic hyperinflation, ventilation-perfusion (V/Q) mismatch, hypoxemia, and increased work of breathing.
PRAM Triage
  • Triage Assessment (Pediatric Respiratory Assessment Measure — PRAM): Mild (PRAM 0–3): Oxygen saturation (SpO2) ≥95%, mild end-expiratory wheeze, no accessory muscle use.
  • Moderate (PRAM 4–7): SpO2 92–94%, moderate expiratory/inspiratory wheezing, intercostal/substernal retractions, tachypnea.
  • Severe/Impending Failure (PRAM 8–12): SpO2 <92% on room air, severe suprasternal/scalene retractions, grunting, poor air entry ("silent chest"), paradoxical thoracoabdominal breathing, agitation, lethargy, or inability to speak full sentences.
SABA ± Ipratropium
  • Comparative Evidence & Pharmacological Rationale — Inhaled Short-Acting β2-Agonists (SABA) vs. Combination with Anticholinergics (SAMA) Monotherapy vs. Dual Therapy: GINA and AAP guidelines endorse adding Ipratropium Bromide to Salbutamol for moderate-to-severe exacerbations in the first hour of ER care.
  • Dual blockade targeting both β2-adrenergic receptors (causing adenylate cyclase activation and bronchial smooth muscle relaxation) and muscarinic M3 receptors (inhibiting parasympathetic bronchoconstriction and acetylcholine-mediated vagal tone) demonstrates synergistic bronchodilation.
  • Evidence:
    • Cochrane Systematic Reviews show adding multiple doses of ipratropium bromide reduces hospital admission rates by 27% (RR 0.73,95% CI 0.63–0.85) and significantly improves FEV1 at 60–120 minutes compared to SABA monotherapy alone.
    • It does not provide additional benefit once admitted to the inpatient ward; its utility is concentrated within the initial ER stabilization window.
    Steroids — Oral ≈ IV
    • Systemic Corticosteroids — Oral Prednisolone vs. Dexamethasone vs. IV Hydrocortisone/Methylprednisolone — Oral vs. Parenteral: Oral administration yields systemic bioavailability and clinical outcomes equivalent to IV routes without the trauma of venous cannulation in moderate distress.
    • Dexamethasone vs. Prednisolone: Dexamethasone has a biological half-life of 36–72 hours versus 12–36 hours for prednisolone, with higher glucocorticoid potency (25−30× hydrocortisone equivalent vs. 4× for prednisolone) and minimal mineralocorticoid activity.
    Evidence:
    • Multiple randomized controlled trials (RCTs) and meta-analyses (e.g., Keeney et al., Pediatrics) demonstrate that 1–2 doses of oral dexamethasone (0.6 mg/kg, max 16 mg) exhibit equivalent rates of symptom resolution and hospital re-admission compared to a 5-day course of prednisolone (1–2 mg/kg/day), with significantly lower rates of emesis (RR≈0.35) and superior compliance.
    IV Magnesium
    • Second-Line Resuscitation — Intravenous Magnesium Sulfate — Mechanism: Competitive inhibition of calcium influx into bronchial smooth muscle cells via voltage-dependent calcium channels, inhibition of acetylcholine release at neuromuscular junctions, and stabilization of mast cell membranes.
    Evidence:
    • In children unresponsive to initial continuous nebulization and systemic steroids, IV MgSO4 (40–50 mg/kg infused over 20–30 minutes) prevents pediatric intensive care unit (PICU) admission and mechanical ventilation (MAGNET trial; Cochrane Review: RR 0.68 for hospitalization).
In-ER Pharmacotherapy (Immediate Resuscitation & Stabilization) — see steps below

1. Inhaled Bronchodilators (Nebulized Duo-Therapy)

    Primary Formulation:
    • Salbutamol: VENTOLIN RESP.SOL. 5MG/MLX20ML (GSK) or VENTOL RESP. SOL (BPC) (Scientific: Salbutamol 5 mg/ml sterile respiratory solution).
    • Ipratropium Bromide: IPRAVENT RESPIRATOR SOLUTION (BPC, 20 ML) or AEROVENT SOLUTION (MSS) (Scientific: Ipratropium Bromide 0.25 mg/ml).
    Weight-Based Dosing:
    • Salbutamol: Weight <20 kg: 2.5 mg (0.5 ml solution) mixed in 2.5 ml normal saline (0.9% NaCl).
    Weight ≥20 kg:
    • 5.0 mg (1.0 ml solution) mixed in 2.0 ml normal saline (0.9% NaCl).
    • Severe/Status: Administer 3 consecutive doses every 20 minutes in the first hour, or back-to-back continuous nebulization (0.5 mg/kg/hour, max 15 mg/hour).
    • Ipratropium Bromide: Weight <20 kg: 250 mcg (1.0 ml of 0.25 mg/ml solution).
    Weight ≥20 kg:
    • 500 mcg (2.0 ml of 0.25 mg/ml solution).
    • Combine directly into the nebulizer chamber with Salbutamol for the first 3 doses (every 20 minutes ×3).
    • Discontinue ipratropium after the first hour; continue salbutamol alone.
    • Diluent: SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 100 ML (Teva).

2. Systemic Glucocorticoids

    Option A — Dexamethasone
    • First-Line (Oral — If able to tolerate fluids and not in extremis): Option A (Dexamethasone Oral Solution): NOVODEXON SYRUP (Beit Jala, 100 ml) (Scientific: Dexamethasone Sodium Phosphate 0.5 mg/5 ml).
    • Dose: 0.6 mg/kg PO once (Maximum single dose: 16 mg).
    • Volume Calculation: 6 ml per 5 kg body weight (e.g., 15 kg child=9 mg=90 ml —note volume burden; if volume is prohibitive for patient, use high-concentration IV formulation administered orally, or prednisolone syrup).
    Option B — Prednisolone
    • Option B (Prednisolone Oral Solution — Low volume): PREDNILET 15 MG SYRUP 60 ML (BPC) or ALLOW 60 ML (Jepharm) or PREDONE SYRUP 15 MG/5ML (Pharmacare Store, 120 ml) (Scientific: Prednisolone 15 mg/5 ml=3 mg/ml).
    • Dose: 2 mg/kg PO stat (Maximum: 60 mg).
    • Volume Calculation: Weight (kg)×0.67 ml (e.g., 15 kg child ×2 mg/kg=30 mg=10 ml 15 kg child×2 mg/kg=30 mg=10 ml PO).
    First-Line (Intravenous - If patient is vomiting, in severe distress, or on continuous positive airway pressure/BiPAP)
    • Methylprednisolone Sodium Succinate: SOLU MEDROL 40 MG/ML or SOLU MEDROL 125MG (Beit Hanina Drug Store).
    • Dose: Loading dose 2 mg/kg IV stat (max 60 mg), then 1 mg/kg IV every 12 hours.
    • Alternative (Hydrocortisone): SOLU CORTEF VIAL 100MG (Beit Hanina Drug Store).
    • Dose: 4 mg/kg IV stat (max 100 mg), then 2–4 mg/kg IV every 6 hours.

    3. Second-Line Adjunct for Severe Unresponsive Exacerbation

      Intravenous Magnesium Sulfate:
      • MAGNESIUM SULFATE KALCEKS 50% 10ML 10 AMP (Medimarket Drug Store) (Scientific: Magnesium sulfate 500 mg/ml [50%]).
      • Dose: 50 mg/kg IV (Maximum absolute dose: 2000 mg=2 g).
      • Preparation & Dilution: Dilute required volume in 100 ml of SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 100 ML (Teva) or DEXTROSE 5% ALISON IV INFUSION 100ML (Alison).
      • Infusion Rate: Infuse IV over 20 to 30 minutes via infusion pump under continuous cardiorespiratory and blood pressure monitoring (to observe for hypotension or hyporeflexia).
    Discharge & Outpatient Transition Regimen

    Criteria for Discharge: PRAM ≤3, room air SpO2 ≥94% sustained for 2 hours post-bronchodilator, feeding well, minimal to no work of breathing.

    1. PREDNILET 15 MG SYRUP 60 ML (BPC)Discharge Rx · verbatim guide

    Scientific: Prednisolone 15 mg/5 ml syrup.
    • Sig: Take [Calculate: 1 mg/kg/day] PO once daily in the morning with food for 3 days.
    • Total duration: 3 to 5 days total (inclusive of ER dose; no taper required).
    2. VENTOLIN RESP.SOL. 5MG/MLX20ML (GSK) [If home jet-nebulizer available] OR Metered-Dose Inhaler with Spacer (if stocked)Discharge Rx · verbatim guide

    Sig: 0.5 ml (2.5 mg) diluted with 2.5 ml of 0.9% Normal Saline via nebulizer every 4–6 hours as needed for cough or wheezing.
    • Wean as symptoms resolve.
    Red Flags & Safety Warnings
    • Silent Chest: Diminishing wheeze in a tiring, tachypneic infant/child indicates imminent respiratory arrest due to air movement failure, not clinical improvement.
    • Hypokalemia & Tachycardia: Frequent high-dose Salbutamol drives potassium intracellularly via the Na+/K+-ATPase pump.
    • Check serum potassium and ECG if the patient receives >6 doses or continuous nebulization.
    • Avoid Sedatives: Benzodiazepines and narcotics are strictly contraindicated due to suppression of hypercapnic respiratory drive.
    Source: PALMEDICS — 1. PEDIATRIC ACUTE ASTHMA & STATUS ASTHMATICUS (full verbatim text).
    2. MODERATE-TO-SEVERE CROUP (LARYNGOTRACHEOBRONCHITIS) 1
    Steroid works fastAAP · Cochrane▾

    2. MODERATE-TO-SEVERE CROUP (LARYNGOTRACHEOBRONCHITIS)

    Westley score · low-dose dexamethasone · nebulized adrenaline

    Background talk — subglottic edema & Westley

    • Clinical Presentation & Diagnostic Triage Pathophysiology: Parainfluenza-induced inflammation causing localized subglottic tracheal edema.
    • Because the cricoid cartilage forms a complete rigid cartilaginous ring, edema expands inward, geometrically increasing airflow resistance (Resistance ∝ 1/r 4 Resistance∝1/r 4 according to Poiseuille’s Law; 1 mm of mucosal edema reduces a pediatric subglottic lumen area by >65%).
    Westley Croup Score
    • Westley Croup Score: Mild (≤2): Barking seal-like cough, hoarse voice, no stridor at rest.
    • Moderate (3–5): Stridor at rest, dynamic sternal wall indrawing/retractions, no agitation.
    • Severe (≥6): Prominent inspiratory (and occasional expiratory) stridor at rest, severe intercostal and suprasternal retractions, lethargy, cyanosis, or air hunger.
    Dexamethasone — Gold Standard
    • Comparative Evidence & Pharmacological Rationale — Systemic Dexamethasone: Single-Dose Oral vs. Inhaled Budesonide vs. L-Epinephrine — Dexamethasone as Gold Standard: Corticosteroids reduce subglottic vascular permeability and mucosal swelling.
    • Dexamethasone has near-absolute clinical superiority over prednisolone in croup due to its prolonged half-life (54 hours vs. 18 hours), preventing the rebound stridor and secondary ER presentations historically seen 24–48 hours post-croup onset.
    • Evidence on Dosing (0.15 mg/kg vs. 0.6 mg/kg): Rigorous RCTs (Dobrovoljac et al.; Cochrane Database) demonstrate that low-dose oral dexamethasone (0.15 mg/kg) is non-inferior to traditional high-dose (0.6 mg/kg) in mild-to-moderate croup regarding symptom resolution, hospitalization rates, and return visits.
    • In severe, life-threatening croup, 0.6 mg/kg (max 16 mg) is maintained to maximize anti-inflammatory receptor saturation.
    • Budesonide vs. Dexamethasone: Nebulized budesonide is equally efficacious to oral dexamethasone in speed of onset; however, oral dexamethasone is less distressing to administer, avoids triggering airway agitation in a struggling toddler, and is significantly more cost-effective.
    • Budesonide is reserved for patients vomiting oral dexamethasone who cannot receive intramuscular injections.
    Racemic vs. L-Epinephrine
    • Nebulized Racemic vs. L-Epinephrine (1: 1000 1:1000): L-Epinephrine (standard 1 mg/ml parenteral formulation) acts via microvascular α 1-adrenergic vasoconstriction in the subglottic mucosa, producing interstitial fluid resorption and rapid airway enlargement within 10–30 minutes.
    • Cochrane systematic reviews show standard L-Epinephrine is bio-equivalent in efficacy and safety to racemic epinephrine, eliminating the need for hard-to-source racemic compounds.
    In-ER Pharmacotherapy (Immediate Resuscitation & Stabilization) — see steps below

    1. Nebulized Epinephrine (For Stridor at Rest/Moderate-to-Severe Retractions)

    • Formulation: ADRENALINE S.A.L.F 1 MG/ML 5 AMP (NOBEL STORE) (Scientific: Epinephrine/Adrenaline 1 mg/ml [1: 1000 1:1000]).
    • Dose & Preparation: Weight <5 kg: 0.5 ml/kg (max 2.5 ml) diluted with equal parts normal saline.
    • Weight ≥5 kg:
      • 5 ml of undiluted
      • Epinephrine 1: 1000 1:1000 (5 mg total) placed directly into the nebulizer chamber.
      • Administration: Driven by high-flow oxygen (6–8 L/min) via mask held gently near the face ("blow-by" if mask causes severe agitation).
      • Onset & Duration: Rapid onset (10–15 minutes); duration of clinical effect lasts 90–120 minutes.
      • Observation Window: Patients receiving nebulized epinephrine must be observed in the ER for a minimum of 2 to 4 hours post-nebulization to evaluate for rebound phenomenon (recurrence of mucosal edema as α 1 -vasoconstriction wanes).

    2. Systemic Glucocorticoids (Administer Stat Concurrently)

      First-Line — Oral Liquid
      • First-Line (Oral Liquid): NOVODEXON SYRUP (Beit Jala, 100 ml) (Scientific: Dexamethasone Sodium Phosphate 0.5 mg/5 ml).
      • Dose: Moderate Croup: 0.15 mg/kg PO single dose (Max 10 mg).
      • Severe/Impending Respiratory Failure: 0.6 mg/kg PO single dose (Max 16 mg).
      • Volume Calculation (0.15 mg/kg): 1.5 ml per 5 kg body weight (e.g., 10 kg child=1.5 mg=15 ml PO).
      Alternative — Parenteral Route
      • Alternative Route (Parenteral - Intramuscular/Intravenous for severe exhaustion, vomiting, or respiratory arrest): DEXA-ALISON 8 MG/2 ML 5 AMP (Alison) or dexamethasone kalceks 4mg/1ml AMP (Medimarket) (Scientific: Dexamethasone Sodium Phosphate 4 mg/ml).
      • Dose: 0.6 mg/kg IM or IV once (Max 16 mg).
      Alternative — Inhaled Route
      • Alternative Inhaled Route (Severe distress + refusal of oral/needle phobia): BUDICORT RESPULES 1MG/2ML - 20 UNITS (Omnipal) or BUDESONIDE STERIN 1MG/2ML (Teva) (Scientific: Budesonide 1 mg/2 ml).
      • Dose: 2 mg (4 ml) nebulized single dose.
      Discharge & Outpatient Transition Regimen

      Discharge Criteria: 3–4 hours elapsed since last epinephrine nebulization, no stridor at rest, normal oxygen saturation on ambient air, clear vesicular breath sounds, normal fluid intake.

      1. Single-Dose ER — Dexamethasone

      Dexamethasone provides complete coverage across the entire 48-to-72-hour vulnerable window; NO ongoing home corticosteroid therapy is indicated for croup.

      2. Cold-mist/humidified air exposure and upright positioning at home.

      3. Antipyresis for comfort:

      ACAMOLI BIG KIDS FRUTI250 SYRUP (Teva, 100 ml)Discharge Rx · verbatim guide

      Scientific: Paracetamol 250 mg/5 ml.
      Sig: Give [Calculate: 15 mg/kg] PO every 4 to 6 hours as needed for fever/distress (Max 4 doses/24 hr).
      Red Flags & Safety Warnings
      • Bacterial Tracheitis/Epiglottitis Differentiation: If high spiking fever (>39.5°C), toxic presentation, preferential tripoding/sniffing position, excessive drooling, lack of a typical barking cough, or failure to respond to nebulized epinephrine occur, do not manipulate the airway.
      • Call ENT and Anesthesiology immediately for controlled operating-room visualization.
      • Minimizing Agitation: Crying exponentially elevates negative intrathoracic inspiratory pressure, precipitating dynamic collapse of the swollen subglottic airway.
      • Conduct physical examinations while the infant remains in the parent's lap; postpone IV placement until nebulized adrenaline and sedation/calming interventions have expanded the airway lumen.
      Source: PALMEDICS — 2. MODERATE-TO-SEVERE CROUP (LARYNGOTRACHEOBRONCHITIS) (full verbatim text).
      3. PEDIATRIC ACUTE GASTROENTERITIS WITH DEHYDRATION & INTRACTABLE EMESIS 1
      Ondansetron then ORSWHO · Freedman NEJM▾

      3. PEDIATRIC ACUTE GASTROENTERITIS WITH DEHYDRATION & INTRACTABLE EMESIS

      single antiemetic · oral rehydration · isotonic fluids only

      Background talk — CDS, ondansetron & isotonic fluids

      • Clinical Presentation & Dehydration Severity Etiology: Predominantly rotavirus, norovirus, or adenovirus leading to enterocyte destruction, brush border enzyme depletion, and secondary osmotic and secretomotor secretory fluid loss.
      Dehydration Scale (CDS)
      • Clinical Dehydration Scale (CDS) Assessment: Mild Dehydration (<5% loss): Moist mucous membranes, normal capillary refill time (<2 s), normal tears, normal skin turgor.
      • Moderate Dehydration (5–9% loss): Tacky/dry mucous membranes, sunken eyes, decreased tearing, delayed capillary refill (2–3 s), deep respirations, irritability.
      • Severe Dehydration (≥10% loss): Parched cracked lips, absent tears, prolonged capillary refill (>3 s), cold mottled extremities, lethargy/somnolence, sunken anterior fontanelle, tachycardia, weak/thready peripheral pulses, oliguria/anuria.
      Antiemetics — Ondansetron
      • Comparative Evidence & Pharmacological Rationale Antiemetic Therapy: Ondansetron vs. Metoclopramide vs. Promethazine
      • Ondansetron Superiority: Ondansetron selectively antagonizes serotonin 5-HT3 5-HT3 receptors both peripherally on vagal nerve terminals in the gastrointestinal tract and centrally within the chemoreceptor trigger zone (CTZ).
      • Comparative Trials (Freedman et al., NEJM): A single dose of oral or IV ondansetron in vomiting children with acute gastroenteritis significantly increases the success rate of Oral Rehydration Therapy (ORT), reduces vomiting frequency, eliminates the need for IV rehydration by >50% (RR 0.41,95% CI 0.28–0.60), and markedly decreases immediate hospital admission rates.
      • Contraindicated Antiemetics: Metoclopramide and promethazine (HISTANYL, PRAMIN) are strongly discouraged in pediatric gastroenteritis due to their significant antidopaminergic central effects, which cause extrapyramidal symptoms (acute dystonias, oculogyric crises), excessive sedation that confounds dehydration assessment, and a black-box warning for fatal respiratory depression in children <2 years.
      Isotonic Fluids Only
      • Fluid Resuscitation — Isotonic Crystalloids vs. Hypotonic — Maintenance Isotonic Protection: AAP guidelines on pediatric intravenous fluids mandate using isotonic crystalloids (0.9% NaCl or Ringer's Lactate) for both emergency expansion and maintenance infusion.
      • Hypotonic fluids (such as 0.18% NaCl or 0.2% NaCl) cause iatrogenic hospital-acquired hyponatremia due to non-osmotic secretion of antidiuretic hormone (ADH) triggered by hypovolemia, nausea, and stress, which can precipitate fatal hyponatremic encephalopathy and cerebral edema.
      In-ER Pharmacotherapy (Immediate Resuscitation & Stabilization) — see steps below

      1. Antiemetic Administration (Prior to Attempting ORT) — Oral (Disintegrating/Crushed Tab), Preferred

      • Formulary Match: ONASET 4mg 10 TAB (Beit Jala) (Scientific: Ondansetron [as HCl dihydrate] 4 mg).
      • Weight-Based Oral Dosing (Single Stat Dose): 8 kg to 15 kg: 2 mg PO (1/2 tablet crushed in 5 ml water/saline). >15 kg to 30 kg: 4 mg PO (1 whole tablet). >30 kg: 8 mg PO (2 tablets).
      Intravenous Option
      • Intravenous (If IV access is established or oral trial fails): ODNATRON 4mg/2ml Amp (CEZAR) or ONDANSETRON KALCEKS 4MG/2ML (Medimarket) (Scientific: Ondansetron 2 mg/ml).
      • Dose: 0.15 mg/kg slow IV push over 2–5 minutes (Max single dose: 4 mg in children <30 kg; 8 mg in children >30 kg).

      2. Rehydration Protocols

      • Wait 15–30 minutes after Ondansetron dose.
      • Administer Oral Rehydration Salts (ORS) solution: 5 ml every 2–5 minutes via oral syringe or small cup.
      • Deficit Goal: 50–100 ml/kg over 4 hours, plus 10 ml/kg for every loose stool, and 2 ml/kg for each vomiting episode.
      • Phase 1:
        • Emergent Volume Resuscitation (Deficit Expansion): SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 500 ML (Teva) or COMPOUND SODIUM LACTATE 500 ML 6 G (MSS)/RINGER LACTATE S.A.L.F 500 ML BOTTLE (Nobel Store).
        • Dose: 20 ml/kg IV bolus administered over 10 to 20 minutes under pressure bag.
        • Reassess perfusion; repeat up to 40–60 ml/kg if the patient remains in hypovolemic shock.
        Phase 2:
        • Deficit Replacement & Maintenance (Post-Shock Stabilization): SODIUM CHLORIDE 0.9% & DEXTROSE 5% ALISON IV INFUSION-12*500ML (Alison) (Scientific: D5 with 0.9% NaCl).
        • Holliday-Segar Maintenance Rate: First 10 kg: 100 ml/kg/day (4 ml/kg/hr).
        • 10–20 kg: 1000 ml +50 ml/kg/day 1000 ml+50 ml/kg/day for each kg over 10 kg (40 ml/hr +2 ml/kg/hr 40 ml/hr+2 ml/kg/hr). >20 kg: 1500 ml +20 ml/kg/day 1500 ml+20 ml/kg/day for each kg over 20 kg (60 ml/hr +1 ml/kg/hr 60 ml/hr+1 ml/kg/hr).
        • Potassium Additive: Add POTASSIUM CHLORIDE 20 ML 14.9% (MSS) at 20 mEq/L (10 ml of 14.9% KCl per 500 ml bag) only after documenting the child has voided urine (confirming adequate renal function and ruling out hyperkalemic acute kidney injury).
        Discharge & Outpatient Transition Regimen

        Discharge Criteria: Emesis controlled for >2 hours, successful completion of ORT trial (>30 ml/kg taken without emesis), normal vital signs, alert, active interaction.

      1. Oral Rehydration Solution (ORS):

      • Continue frequent, small-volume replacement: 10 ml/kg after each diarrheal stool.
      • Resume age-appropriate diet immediately (complex carbohydrates, lean meats, yogurt); avoid simple sugars, high-fat foods, and juice (worsens osmotic diarrhea).

      2. Antidiarrheal/Antispasmodic Contraindication Notice: NO loperamide (DIACARE), diphenoxylate, or hyoscine (SCOBUTYL) should be prescribed.

      • These agents carry a high risk of toxic megacolon, paralytic ileus, and central toxicity.

      3. Antipyresis (If Febrile):

      • Avoid Ibuprofen in dehydrated children due to amplified risk of acute renal tubular necrosis.*
      PARAMOL EXTRA SUSP 250 MG (Beit Jala, 100 ml)Discharge Rx · verbatim guide

      Scientific: Paracetamol 250 mg/5 ml.
      Sig: Give [Calculate: 15 mg/kg] PO every 4 to 6 hours as needed for discomfort (Max 60 mg/kg/day).
      Red Flags & Safety Warnings
      • QTc Prolongation: Ondansetron can prolong the myocardial QTc interval. Avoid in patients with congenital long QT syndrome or those taking concurrent QTc-prolonging medications.
      • Masking Surgical Abdomen: Do not administer repeated doses of antiemetics if the child exhibits localized abdominal tenderness, rebound tenderness, bilious (dark green) vomiting, or hematochezia.
      • These findings suggest surgical pathologies, including intussusception, appendicitis, or malrotation with midgut volvulus.
      Source: PALMEDICS — 3. PEDIATRIC ACUTE GASTROENTERITIS WITH DEHYDRATION & INTRACTABLE EMESIS (full verbatim text).
      4. SEVERE PEDIATRIC INFECTIONS & BACTERIAL MENINGITIS / SEPSIS 1
      Antibiotics within 1 hourIDSA · NICE NG240▾

      4. SEVERE PEDIATRIC INFECTIONS & BACTERIAL MENINGITIS / SEPSIS

      neonatal cefotaxime rule · ceftriaxone + vancomycin · dexamethasone adjunct

      Background talk — sepsis, meningitis & cephalosporins

      • Clinical Presentation & Diagnostic Triage — Pediatric Sepsis/Septic Shock Indicators: Tachycardia disproportionate to fever, prolonged capillary refill (>3 seconds) or hyperdynamic "flash" capillary refill, bounding or absent peripheral pulses, temperature instability (<36°C or >38.5°C), altered mental status (unresponsiveness, irritability, weak cry), and non-blanching purpuric or petechial rash (suggesting meningococcemia).
      Meningitis Signs
      • Bacterial Meningitis Signs: High fever, bulging anterior fontanelle, nuchal rigidity, Kernig's and Brudzinski's signs (unreliable in children <12–18 months), intractable irritability, paradoxical crying (crying intensifies when held by parents due to meningeal stretch), seizures, and lethargy.
      Ceftriaxone vs. Cefotaxime
      • Comparative Evidence & Pharmacological Rationale — Third-Generation Cephalosporin Selection: Ceftriaxone vs. Cefotaxime in Neonates vs. Older Infants — The Neonatal Rule (<28 Days of Life): Cefotaxime (CEFOTAXIM) is the mandatory third-generation cephalosporin for neonates; Ceftriaxone (SAMIXON, CEFIXON) is contraindicated in neonates.
      • Mechanism of Toxicity:
        • Ceftriaxone has high protein binding (95%), aggressively displacing bilirubin from serum albumin binding sites, which substantially elevates unbound free bilirubin and precipitates kernicterus (bilirubin encephalopathy).
        • Calcium Precipitation: Ceftriaxone forms insoluble crystalline precipitates with calcium salt formulations (CALCIUM GLUCONATE 10%), which can deposit irreversibly in neonatal pulmonary and renal microvasculature, causing fatal emboli.
        Age ≥29 Days
        • Infants and Children (≥29 Days): Ceftriaxone is the primary first-line empiric agent due to its once- or twice-daily dosing, high bactericidal activity against Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae, and reliable blood-brain barrier penetration in inflamed meninges.
        • Ampicillin Indication in Neonates: Listeria monocytogenes and Enterococcus faecalis are pathogens seen in the first month of life; both have natural resistance to all cephalosporins due to low affinity for cephalosporin-binding penicillin-binding proteins (PBPs).
        • Therefore, Ampicillin (PENIBRIN) must be combined with Cefotaxime or Gentamicin in any neonate <28 days presenting with suspected sepsis or meningitis.
        Vancomycin Add-On
        • Addition of Vancomycin: IDSA and AAP guidelines mandate combining high-dose Vancomycin with a third-generation cephalosporin in suspected meningitis or severe sepsis due to the global prevalence of cephalosporin-resistant Streptococcus pneumoniae and Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA).
      In-ER Pharmacotherapy (Immediate Resuscitation & Stabilization) — see steps below

      1. Immediate Fluid Resuscitation (Septic Shock)

      • Formulary Match: SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 500 ML (Teva) or RINGER LACTATE S.A.L.F 500 ML BOTTLE (Nobel Store).
      • Dose: Rapid bolus of 10–20 ml/kg IV over 5 to 10 minutes.
      • Reassessment Target: Re-evaluate for hepatomegaly, pulmonary crackles, heart rate, and capillary refill after each aliquot.
      • Stop boluses if rales or new gallop rhythm develops (indicating fluid overload and myocardial dysfunction).

      2. Empiric Antimicrobial Regimens

        Drug 1 — Ampicillin
        • Drug 1 (Ampicillin): PENIBRIN 1 GM VIAL (Teva) (Scientific: Ampicillin Sodium 1 g).
        • Dose: 100 mg/kg/dose IV every 6 hours (for meningitis) or 50 mg/kg/dose IV every 8 hours (for sepsis).
        • Reconstitution: Reconstitute with sterile water for injection; administer IV push over 10–15 minutes.
        Drug 2 — Cefotaxime
        • Drug 2 (Cefotaxime - Preferred): CEFOTAXIM 1G vial (Jepharm) or CLAFOXIM 1 GM VIAL (BPC) (Scientific: Cefotaxime Sodium 1 g).
        • Dose: 50 mg/kg/dose IV every 6 hours (Meningitis dose: 200 mg/kg/day divided q6h).
        • Administration: IV intermittent infusion over 30 minutes.
        Alternative to Cefotaxime (if unavailable or for synergistic Gram-negative sepsis) — Gentamicin
        • Gentamicin: GENTICIN 40 MG/2ML 100 AMP (Jepharm) (Scientific: Gentamicin Sulfate 20 mg/ml).
        • Dose: 4–5 mg/kg IV once every 24 hours infused over 30 minutes.
        Drug 1 — Ceftriaxone
        • Drug 1 (Ceftriaxone): SAMIXON 1000 MG IV (Pharmacare Store) or CEFIXON 1G VIAL (BPC) or TIXON 1 GM VIAL (Jepharm).
        • Dose (Meningitis): 100 mg/kg/day IV divided every 12 hours (or 100 mg/kg once daily; max single dose: 2000 mg=2 g).
        • Dose (Sepsis without Meningitis): 50–75 mg/kg/day IV once daily or divided q12h (max 2 g/day).
        • Infusion: Reconstitute with sterile water; dilute in 50–100 ml of 0.9% NaCl; infuse over 30 minutes.
        Drug 2 — Vancomycin
        • Drug 2 (Vancomycin): VANCOAVENIR VIAL 500MG (Beit Al-Dawaa) or Vancomycin Hikma 500 MG (Pharmacare Store) (Scientific: Vancomycin HCl 500 mg).
        • Dose: 15–20 mg/kg/dose IV every 6 hours (Total daily dose: 60 mg/kg/day; max single dose: 1000 mg).
        • Infusion Safety: Dilute to a concentration ≤5 mg/ml in 0.9% NaCl.
        • Infuse slowly over a minimum of 60 minutes (or rate ≤10 mg/min) to avoid Red Man Syndrome (mast cell degranulation-mediated histamine release causing profound hypotension, erythema, and bronchospasm).

        3. Meningitis Corticosteroid Adjunct (Attenuating Hearing Loss)

        • Dexamethasone IV: DEXA-ALISON 8 MG/2 ML 5 AMP (Alison) (Scientific: Dexamethasone Sodium Phosphate 4 mg/ml).
        • Dose: 0.15 mg/kg IV administered 10–20 minutes before or concurrently with the first antibiotic dose.
        • Clinical Target: Attenuates inflammatory subarachnoid cytokine cascades (TNF-α TNF-α, IL-1β IL-1β) released when bactericidal antibiotics lyse bacteria; prevents sensorineural deafness in H. influenzae type b and S. pneumoniae meningitis.
        Admission Required
        • Inpatient Admission Requirement: Outpatient transition is contraindicated in suspected bacterial meningitis or septic shock.
        • Children must be transferred directly from the ER to an inpatient pediatric step-down or PICU facility via mobile intensive care.
        Red Flags & Safety Warnings
        • Lumbar Puncture (LP) Contraindications:
        • Do not delay antimicrobials for an LP.
        • Defer LP and immediately administer antibiotics if the child has cardiovascular instability/shock, progressive purpuric rash, focal neurological deficits, signs of raised intracranial pressure (hypertension, bradycardia, irregular breathing=Cushing's triad; fixed, dilated, or sluggish pupils), or platelets <50,000/μL.
        • Avoid Calcium + Ceftriaxone
        • Mixtures: Never infuse calcium-containing fluids (e.g., Ringer's Lactate) through the same IV line as Ceftriaxone, regardless of patient age; use separate lines or thoroughly flush between infusions.
        Source: PALMEDICS — 4. SEVERE PEDIATRIC INFECTIONS & BACTERIAL MENINGITIS / SEPSIS (full verbatim text).
        5. PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA (CAP) 1
        High-dose amoxicillinBTS · IDSA▾

        5. PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA (CAP)

        typical vs atypical · outpatient and inpatient regimens

        Background talk — causes, tachypnea & amoxicillin

        • Clinical Presentation & Diagnostic Triage Pathophysiology: Infiltration of microbial pathogens causing alveolar exudate, consolidation, and ventilation impairment.
        Causes by Age
        • Causative agents vary by age: Neonates: Group B Streptococcus, Gram-negative enteric bacilli.
        • 3 Months to 5 Years: Viruses (RSV, Metapneumovirus, Influenza), followed by Streptococcus pneumoniae.
        • School-age (>5 Years): Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae.
        WHO Tachypnea + Admission Criteria
        • WHO Tachypnea Thresholds at Rest: Age <2 months: ≥60 breaths/min Age 2–11 months: ≥50 breaths/min Age 1–5 years: ≥40 breaths/min Age >5 years: ≥30 breaths/min Severe Criteria Mandating Admission: Grunting, chest indrawing, nasal flaring, SpO2 <92%, lethargy, inability to feed, or pleural effusion/empyema on bedside ultrasound/radiograph.
        High-Dose Amoxicillin
        • Comparative Evidence & Pharmacological Rationale — High-Dose Amoxicillin as First-Line Empiric Therapy: Streptococcus pneumoniae is the primary bacterial pathogen in typical pediatric CAP across all age groups beyond the neonatal period.
        • High-Dose Strategy (90 mg/kg/day vs. Standard 40–45 mg/kg/day): Penicillin-resistant S. pneumoniae (PRSP) alters penicillin-binding protein targets (PBP-1a PBP-1a, PBP-2x PBP-2x, PBP-2b PBP-2b).
        • This resistance is competitive and non-enzymatic (it is not mediated by β-lactamases).
        • Clinical Pearl: Adding clavulanic acid does not overcome penicillin-binding protein alterations.
        • Therefore, Amoxicillin monotherapy (AMOXICARE, AMOXITID) at a high dose of 90 mg/kg/day achieves middle-ear and alveolar fluid concentrations that exceed the minimum inhibitory concentration (MIC) of intermediately and highly resistant pneumococci, without adding the secretory diarrhea risk associated with clavulanate.
        Empiric Atypical Coverage (Macrolides): When and Why?
        • Routine coverage for atypical pathogens (Mycoplasma, Chlamydophila) with macrolides (AZICARE, KLARIMAX) is unwarranted in preschool-aged children (<5 years), in whom typical bacterial and viral etiologies predominate.
        • In children ≥5 years presenting with subacute onset, low-grade fevers, prominent constitutional signs, bilateral interstitial/broncho-infiltrates on auscultation, or non-response to β -lactams, adding a macrolide targeting the 50S ribosomal subunit is guideline-recommended (BTS/IDSA Pediatric CAP Guidelines).
        In-ER Pharmacotherapy (Immediate Resuscitation & Stabilization) — see steps below

        1. Inpatient/Severe CAP Resuscitation — First-Line IV Therapy (Typical Severe Bacterial CAP)

        • Formulary Match: SAMIXON 1000 MG IV (Pharmacare Store) or CEFIXON 1G VIAL (BPC) (Scientific: Ceftriaxone 1 g).
        • Dose: 50–80 mg/kg/day IV once daily (Max 2000 mg).
        Alternative — Ampicillin
        • Alternative (Narrow-Spectrum for Fully Immunized Child with Lobar Consolidation): PENIBRIN 1 GM VIAL (Teva) (Scientific: Ampicillin 1 g).
        • Dose: 50 mg/kg/dose IV every 6 hours (200 mg/kg/day; max 2 g/dose).
        Atypical Adjunct (≥5 Years)
        • Atypical Presentation Adjunct (Age ≥5 Years, Suspected Mycoplasma): AZITHROMYCIN MBI 500 MG/VIAL 1 VIAL (Beit Al-Dawaa) or ZITHROMAX 500 mg/Vial (Beit Hanina Drug Store).
        • Dose: 10 mg/kg IV on Day 1 (max 500 mg), then 5 mg/kg IV once daily (max 250 mg) infused over 60 minutes.
        Discharge & Outpatient Transition Regimen

        Criteria for Outpatient Care: Mild-to-moderate CAP, normal hydration, SpO2 ≥94% on room air, reliable caregiver, able to tolerate oral medication without emesis.

          Option 1 — Under 5 Years (Typical CAP)
          • Option 1: First-Line for Children <5 Years (Typical CAP)
          AMOXICARE 400 MG SUSPENSION 100 ML (Pharmacare Company) [OR AMOXITID 400MG GRAN 70 ML (BPC) OR MOXEPHARM 400 SUSP.70 ML. (Jepharm)]Discharge Rx · verbatim guide

          Scientific: Amoxicillin (as trihydrate) 400 mg/5 ml. Dose: 90 mg/kg/day divided into 2 equal doses (every 12 hours) with meals.
          • Duration: 5 to 7 days (IDSA/AAP guidelines support shorter, high-dose courses).
          • Math Calculation Example: - Patient Weight: 12 kg. - Daily Dose: 12 kg x 90 mg/kg=1080 mg/day. - Divided Q12H: 540 mg per dose. - Volume per dose: (540 mg/400 mg) x 5 ml=6.75 ml PO BID.
          • Sig: Give 6.75 ml by mouth every 12 hours for 7 days.
          Option 2 — 5 Years+ (Atypical)
          • Option 2: First-Line for Children ≥5 Years with Suspected Atypical Pneumonia
          AZICARE 200 SUSPENSION (Pharmacare Company) [OR ZITROCIN 15ML DRY SUSPENSION (Jepharm)]Discharge Rx · verbatim guide

          Scientific: Azithromycin 200 mg/5 ml. Dose: 10 mg/kg on Day 1 (max 500 mg), followed by 5 mg/kg once daily on Days 2 through 5 (max 250 mg).
          • Math Calculation Example: - Patient Weight: 20 kg. - Day 1 Dose: 20 kg x 10 mg/kg=200 mg=5.0 ml PO once. - Days 2–5 Dose: 20 kg x 5 mg/kg=100 mg=2.5 ml PO once daily.
          • Sig: Give 5 ml on Day 1, then 2.5 ml once daily on Days 2,3, 4, and
          5. Take 1 hour before or 2 hours after meals.
          • Option 3: Penicillin-Allergic Child (Non-Type 1/Non-Anaphylactic Hypersensitivity)
          ADCEF 250 MG SUSP.60 ML (Pharmacare Company) [OR CEFIMED 250 MG 60 ML SUSP (BPC)]Discharge Rx · verbatim guide

          Scientific: Cefdinir 250 mg/5 ml. Dose: 14 mg/kg/day divided every 12 hours (or once daily) for 7 days (Max: 600 mg/day).
          • Math Calculation: - Patient Weight: 15 kg ->210 mg/day ->105 mg BID ->2.1 ml PO twice daily.
          Red Flags & Safety Warnings
          • Parapneumonic Effusion/Empyema: Worsening respiratory distress, persistent high fevers past 48 hours of compliant antibiotics, or asymmetric absent breath sounds at the lung bases require immediate ultrasound or chest radiography to evaluate for fluid accumulation that may require chest tube thoracostomy.
          • Cough Suppressants: Antitussives and opioid combinations (TUSSIBAL COMPOUND, BRONCHOLATE FORTE) are contraindicated in pneumonia.
          • Suppressing the physiological cough reflex leads to mucus plugging, alveolar atelectasis, and clinical deterioration.
          Source: PALMEDICS — 5. PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA (CAP) (full verbatim text).
          6. ACUTE OTITIS MEDIA (AOM) & BACTERIAL SINUSITIS 1
          14:1 ratioAAP▾

          6. ACUTE OTITIS MEDIA (AOM) & BACTERIAL SINUSITIS

          high-dose amoxicillin · ES-600 clavulanate cap · mastoiditis screen

          Background talk — AOM, sinusitis & 14:1

          • Clinical Presentation & Diagnostic Triage — Diagnostic Criteria (AAP Guidelines): Acute onset of ear pain (tugging/rubbing in infants), intense erythema, and moderate-to-severe bulging of the tympanic membrane (or new-onset otorrhoea not caused by otitis externa).
          Severe AOM
          • Severe AOM: Moderate to severe otalgia, otalgia lasting ≥48 hours, or temperature ≥39°C.
          Sinusitis Presentation
          • Bacterial Sinusitis Presentation: Persistent purulent rhinorrhea and daytime cough lasting >10 days without improvement, worsening symptoms ("double sickening"), or high fever (≥39°C) with purulent nasal discharge for 3 consecutive days.
          Comparative Evidence & Pharmacological Rationale Amoxicillin Monotherapy vs. High-Dose Amoxicillin-Clavulanate (14:1 Ratio)
          • Pathogen Shift: While S. pneumoniae without β -lactamase was historically the most common cause of AOM, non-typeable Haemophilus influenzae and Moraxella catarrhalis produce β-lactamases that rapidly hydrolyze amoxicillin.
          • Indications for Amoxicillin-Clavulanate: Indicated when the child has received amoxicillin in the past 30 days, has concurrent purulent conjunctivitis ("otitis-conjunctivitis syndrome", indicative of H. influenzae), or fails first-line high-dose amoxicillin after 48–72 hours.
          • Why the 14: 1 Formulation (Augmentin ES-600) is Required: Standard Amox/Clav formulations (such as 4:1 or 7:1; Augmentin 400mg/70ml, CLAMOXIN 400) deliver high, unneeded doses of clavulanic acid when dosed at 90 mg/kg/day of the amoxicillin component.
          • Clavulanic acid stimulates gastrointestinal motility via serotonin and motor receptor pathways, causing severe diarrhea and cramping.
          • Augmentin Syrup ES 600mg or CLAMOXIN 600 mg SUSP delivers 600 mg amoxicillin and 42.9 mg clavulanic acid per 5 ml (a 14:1 ratio).
          • This achieves the necessary 90 mg/kg/day amoxicillin concentration to overcome resistant pneumococci while capping the clavulanate dose at ≈6.4 mg/kg/day, minimizing the incidence of secretory diarrhea.
          Outpatient Pediatric Prescriptions — First-Line Prescription: Uncomplicated AOM (No Amoxicillin in Past 30 Days, No Conjunctivitis)
          AMOXICARE 400 MG SUSPENSION 100 ML (Pharmacare Company)Discharge Rx · verbatim guide

          Scientific: Amoxicillin 400 mg/5 ml. Dose: 90 mg/kg/day PO divided every 12 hours with meals.
          • Duration: - Age <2 years or Severe AOM: 10 full days. - Age 2–5 years (Mild-to-moderate): 7 days. - Age >=6 years: 5 to 7 days.
          • Calculation (10 kg infant): - 10 kg x 90 mg/kg=900 mg/day=450 mg Q12H. - Volume: 5.6 ml PO twice daily.
          First-Line for Resistant AOM/Sinusitis/Concurrent Conjunctivitis/Recent Beta-Lactam Use
          Augmentin Syrup ES 600mg/100ml (GSK) [OR CLAMOXIN 600 mg SUSP 75 ml (Jepharm) OR OGMIN 600 MG GRAN 100 ML (BPC)]Discharge Rx · verbatim guide

          Scientific: Amoxicillin 600 mg + Clavulanic Acid 42.9 mg per 5 ml (14:1 Ratio).
          • Dose: 90 mg/kg/day (based on amoxicillin component) PO divided every 12 hours with food.
          • Duration: 10 days for children <2 years; 7 days for children >=2 years.
          • Math Calculation Example: - Patient Weight: 14 kg. - Daily Amoxicillin Target: 14 kg x 90 mg/kg=1260 mg/day. - Dose per administration (BID): 630 mg. - Volume: (630 mg/600 mg) x 5 ml=5.25 ml PO every 12 hours.
          • Sig: Give 5.25 ml by mouth twice daily at the start of a meal for 10 days.
          Alternative for Non-Type 1 Penicillin Allergy
            ZINNAT SUSP. 250MG/5ML 100 ML (MASROUJI CO.) [OR CEFIMED 250 MG 60 ML SUSP (BPC)/ADCEF 250 MG SUSP (Pharmacare)]Discharge Rx · verbatim guide

            Scientific: Cefuroxime (as axetil) 250 mg/5 ml. Dose: 30 mg/kg/day PO divided every 12 hours with food for 10 days (Max: 1000 mg/day).
            • Calculation (15 kg child): - 15 kg x 30 mg/kg=450 mg/day=225 mg BID=4.5 ml PO twice daily.
            In-ER Rescue (IM Ceftriaxone)
            • In-ER Rescue for Intractable Vomiting/Failure of Second-Line Oral Therapy: SAMIXON 1000 MG IM (Pharmacare Store, with Lidocaine solvent) or CEFIXON 1G VIAL + LIDOCAINE (BPC).
            • Dose: 50 mg/kg IM once daily for 1 to 3 consecutive days.
            • Clinical Rationale: Reconstituting with 1% lidocaine provides localized anesthesia, making deep IM gluteal/anterolateral thigh injection tolerable in pediatric outpatients.
            Red Flags & Safety Warnings
            • Mastoiditis Screening: Examine behind the auricle in every child presenting with AOM.
            • Post-auricular swelling, erythema, tenderness, and downward/outward displacement of the pinna indicate acute mastoiditis, which requires emergency CT imaging, admission, IV ceftriaxone, and urgent ENT consultation for possible cortical mastoidectomy.
            • Do Not Use Ineffective Antibiotics: Azithromycin, clarithromycin, and trimethoprim-sulfamethoxazole (SULFAPRIM) demonstrate unacceptably high clinical failure rates (>30–50%) against S. pneumoniae and H. influenzae in AOM due to established ribosomal and folate-pathway resistance mutations; their use should be limited to verified, severe anaphylactic penicillin allergies.
            Source: PALMEDICS — 6. ACUTE OTITIS MEDIA (AOM) & BACTERIAL SINUSITIS (full verbatim text).
            7. PEDIATRIC STATUS EPILEPTICUS & PROLONGED FEBRILE SEIZURES 1
            Time-criticalILAE · RAMPART▾

            7. PEDIATRIC STATUS EPILEPTICUS & PROLONGED FEBRILE SEIZURES

            intranasal midazolam · levetiracetam second line · glucose check

            Background talk — T1/T2, RAMPART & second-line

            Clinical Presentation & Time-Critical Physiology Operational Definition (ILAE Guidelines)
            • T1 (5 minutes): Seizure activity lasting ≥5 minutes (or ≥2 discrete seizures without full recovery of consciousness between events).
            • Emergency pharmacotherapy must be initiated immediately; continuous seizure activity beyond 5 minutes rarely terminates spontaneously and leads to receptor remodeling.
            • T2 (30 minutes): Seizures persisting beyond 30 minutes cause systemic hyperpyrexia, rhabdomyolysis, metabolic acidosis, irreversible neuronal necrosis, and pharmacoresistance.
            • Pathophysiologic Mechanism: Prolonged continuous seizures drive GABA-A GABA-A receptor endocytosis and degradation from the synaptic membrane, alongside upregulation and surface mobilization of excitatory NMDA and AMPA receptors.
            • Consequence: Benzodiazepines become progressively less potent with every minute of ongoing seizure activity, making prompt initial administration critical.
            First-Line Benzo (RAMPART)
            • Comparative Evidence & Pharmacological Rationale — First-Line Emergent Benzodiazepine: Intramuscular/Intranasal Midazolam vs. Rectal/IV Diazepam — The RAMPART Trial (Silbergleit et al., NEJM): In pediatric and adult status epilepticus without established IV access, intramuscular (IM) midazolam was superior to intravenous lorazepam in terminating seizures before ER arrival (73.4% vs. 63.4%) and resulted in fewer hospitalizations and lower rates of assisted endotracheal intubation.
            • Why Midazolam Outperforms Diazepam: Midazolam is water-soluble at acidic vial pH but becomes lipophilic at physiologic blood pH (7.4), allowing rapid absorption across nasal and buccal mucosae and muscle compartments.
            • Rectal Diazepam Limitations: Rectal administration of diazepam (SEREPAM AMP given rectally or suppository formulations) has erratic, delayed bioavailability (T max ≈20–45 minutes), is socially stigmatizing, and is challenging to retain during pelvic convulsive movements.
            • Intranasal (IN) or IM midazolam terminates seizures significantly faster than rectal diazepam (median time to cessation: 3–5 minutes vs. 8–12 minutes).
            Second-Line (ConSEPT/EcLiPSE)
            • Second-Line Anticonvulsant Therapy: IV Levetiracetam vs. Phenobarbital
            • The ConSEPT and EcLiPSE Trials (The Lancet 2019): Evaluated second-line agents for benzodiazepine-refractory pediatric status epilepticus.
            • Levetiracetam was found to be non-inferior to fosphenytoin/phenytoin in safety and efficacy (50–60% seizure cessation at 30 minutes).
            • Advantages of Levetiracetam: Levetiracetam binds to synaptic vesicle protein 2 A 2A (SV2A), inhibiting presynaptic vesicle exocytosis and neurotransmitter release.
            • Unlike phenytoin or phenobarbital, Levetiracetam does not cause cardiovascular collapse, cardiac conduction arrhythmias, or profound hypotension, and it avoids respiratory depression that would otherwise necessitate preemptive intubation.

            In-ER Pharmacotherapy (Immediate Resuscitation & Stabilization)

              Algorithm Stage 1:
              • Initial Stabilization & Benzodiazepines (0–10 Minutes)
              • Formulation: MIDAZOLAM KALCEKS 5 MG/ML 3ML 10 AMP (Medimarket) or MIDOLAM 5MG/ML AMP/5 AMP (Syam) (Scientific: Midazolam 5 mg/ml).
              Intranasal (Preferred)
              • Intranasal (IN) Administration (Preferred): Dose: 0.2 mg/kg (Max single dose: 10 mg).
              • Administration: Draw calculated volume using a 1 ml syringe.
              • Atomize half of the volume into each nostril using an atomization device (or drip slowly along nasal mucosa if an atomizer is unavailable).
              Intramuscular
              • Intramuscular (IM) Administration: Dose: 0.2 mg/kg deep into the anterolateral thigh muscle (Max 10 mg).
              • Volume Calculation Example (5 mg/ml concentration): 10 kg child ×0.2 mg/kg=2 mg=0.4 ml 10 kg child×0.2 mg/kg=2 mg=0.4 ml total volume.
              • 15 kg child ×0.2 mg/kg=3 mg=0.6 ml 15 kg child×0.2 mg/kg=3 mg=0.6 ml total volume.
              IV Option 1 — Midazolam
              • Formulation Option 1 (Midazolam IV): MIDAZOLAM KALCEKS 1 MG/ML 5MG AMP (Medimarket) or MIDAZOLAM 5mg/1ml Amp.
              • Dose: 0.1–0.15 mg/kg IV push over 1–2 minutes (Max 5 mg).
              IV Option 2 — Diazepam
              • Formulation Option 2 (Diazepam IV): SEREPAM 10 MG AMP 5 AMP (BPC) (Scientific: Diazepam 10 mg/2 ml=5 mg/ml).
              • Dose: 0.2–0.3 mg/kg slow IV push over 2 minutes (Max single dose: 5 mg in children <5 years; 10 mg in children ≥5 years).
              • Repeat Rule: If seizure persists after 5 minutes, repeat a single identical dose of benzodiazepine once.
              • Prepare for airway support.
              Algorithm Stage 2:
              • Benzodiazepine-Refractory Status (10–30 Minutes) Initiate second-line therapy if seizures continue despite 2 adequate doses of benzodiazepines.
              • Intravenous Levetiracetam (Keppra equivalent): Levebon (Al Bayan Drug Store) (Scientific: Levetiracetam 100 mg/ml solution, 10 vials ×5 ml 10 vials×5 ml).
              • Dose: 60 mg/kg IV (Maximum absolute dose: 4500 mg).
              • Preparation & Dilution: Dilute the calculated volume into 50–100 ml of SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 100 ML (Teva).
              • Infusion Rate: Infuse IV over 10 to 15 minutes.
              • Math Example: 15 kg child ×60 mg/kg=900 mg=9 ml of Levebon 15 kg child×60 mg/kg=900 mg=9 ml of Levebon in 50 ml 0.9% NaCl over 10 min.
              Algorithm Stage 3:
              • Refractory Status Epilepticus (>30 Minutes) Seizures persisting past second-line infusion represent refractory status epilepticus.
              • Escalate immediately to rapid sequence induction (RSI) with endotracheal intubation, continuous midazolam infusion, or secondary adjuncts.
              RSI Kit
              • Rapid Sequence Intubation Induction: Ketamine: KITAMINE PANPHARMA 50mg/1ml 25 VIAL (True med) or KETAMINE G.L.
              • 10 MG/ML (Dose: 1.5–2 mg/kg IV).
              • Paralytic (Neuromuscular Blocker): Rocuronium bromide kalceks 10mg/ml (Medimarket) (Dose: 1.0–1.2 mg/kg IV).
              Discharge & Outpatient Transition (Febrile Seizures)

              Children with simple febrile seizures that resolve rapidly and have an identifiable, treatable infectious source (such as AOM or viral upper respiratory tract infection) can be safely discharged after a minimum 4-hour period of normal neurological recovery.

            1. No maintenance daily anti-seizure medication (Phenobarbital/Levetiracetam) is indicated for simple febrile seizures.
            2. Parent Education: Antipyretics reduce fever and provide comfort, but they do NOT prevent febrile seizure recurrence.

            3. Antipyresis Regimen:

            ADVIL CHILDREN'S GRAPE FLAVOR (MSS, 120 ml)Discharge Rx · verbatim guide

            Scientific: Ibuprofen 100 mg/5 ml.
            Sig: Give [Calculate: 10 mg/kg] PO every 6 to 8 hours with meals as needed for fever/distress. (Max single dose: 400 mg; Max daily: 40 mg/kg/day).
            Red Flags & Safety Warnings
            • Hypoglycemia Check: Obtain a point-of-care capillary blood glucose immediately in all seizing children.
            • If glucose is <60 mg/dL (<3.3 mmol/L): Administer DEXTROSE 10% ALISON IV INFUSION 500ML (Alison) at 2–5 ml/kg IV bolus (0.2–0.5 g/kg elemental dextrose).
            • Recheck blood glucose after 10 minutes.
            • Respiratory Arrest from Benzodiazepine Stacking: Administering >2 doses of benzodiazepines substantially increases the risk of loss of airway reflexes and central apnea.
            • Have a pediatric bag-valve-mask (BVM), suction, appropriately sized endotracheal tubes, and rescue devices ready at the bedside.
            Source: PALMEDICS — 7. PEDIATRIC STATUS EPILEPTICUS & PROLONGED FEBRILE SEIZURES (full verbatim text).
            8. PEDIATRIC ANAPHYLAXIS & SEVERE ALLERGIC EMERGENCIES 1
            Thigh nowWAO · EAACI▾

            8. PEDIATRIC ANAPHYLAXIS & SEVERE ALLERGIC EMERGENCIES

            intramuscular adrenaline · flat with legs up · biphasic watch

            Background talk — WAO criteria & epinephrine first

            • Clinical Presentation & Diagnostic Criteria — Diagnostic Definition (WAO/EAACI): Anaphylaxis is a severe, life-threatening generalized systemic hypersensitivity reaction characterized by rapid onset (minutes to hours) with life-threatening airway, breathing, or circulatory problems.
            Diagnosis (Any 1 of 3)
            • Diagnostic Scenarios (Any 1 of 3): Acute onset of skin/mucosal tissue involvement (hives, flushing, swollen lips/tongue/uvula) plus ≥1 of: Respiratory compromise (dyspnea, wheeze, bronchospasm, stridor, hypoxemia).
            • Reduced blood pressure or associated symptoms of end-organ dysfunction (hypotonia, syncope, incontinence).
            • Two or more of the following occurring rapidly after exposure to a likely allergen for that patient: Skin/mucosal involvement.
            • Respiratory compromise.
            • Reduced blood pressure or associated symptoms.
            • Persistent, crampy gastrointestinal symptoms (severe abdominal pain, vomiting).
            • Reduced blood pressure after exposure to a known allergen for that patient (systolic BP <70 mmHg + [2 × age in years] <70 mmHg+[2×age in years] for children 1–10 years).
            Epinephrine IM Thigh First
            • Comparative Evidence & Pharmacological Rationale — Epinephrine as First-Line Therapy: The Intramuscular (IM) Thigh Route — Epinephrine is the Only Life-Saving Intervention: It reverses peripheral vasodilation and vascular permeability via α 1 -receptors, relieves bronchospasm and mucosal edema via β2 -receptors, and increases myocardial contractility and suppresses mast cell/basophil mediator release via intracellular cAMP elevation (β 1/β2).
            • Evidence for the Anterolateral Thigh Route:
              • Simons et al. (J Allergy Clin Immunol) demonstrated that intramuscular injection into the vastus lateralis (anterolateral thigh) achieves peak plasma epinephrine concentrations (Cmax) significantly faster and at higher levels than injection into the deltoid muscle or subcutaneous tissue.
              • Subcutaneous absorption is delayed due to localized α 1 -mediated vasoconstriction.
              • Mortality Associated with Delayed Administration: Fatal pediatric anaphylaxis is consistently linked to delayed administration of epinephrine and reliance on antihistamines or corticosteroids as initial therapy.
              Antihistamines/Corticosteroids Second
              • Antihistamines & Corticosteroids — Secondary Role — Antihistamines (Promethazine, Cetirizine): Only relieve cutaneous pruritus and urticaria; they do not reverse airway obstruction, laryngeal edema, or circulatory collapse.
              • Corticosteroids (Hydrocortisone, Methylprednisolone): Have an onset of action of 4 to 6 hours.
              • Cochrane Reviews and recent EAACI guidelines show systemic corticosteroids do not prevent biphasic anaphylaxis, which occurs in 5–15% of patients.
              • They serve strictly as secondary anti-inflammatory stabilizers and must never delay epinephrine.
            In-ER Pharmacotherapy (Immediate Resuscitation & Stabilization) — see steps below

            1. First-Line Emergent Intervention (Administer Immediately)

            • Intramuscular Epinephrine (1: 1000 1:1000): ADRENALINE S.A.L.F 1 MG/ML 5 AMP (NOBEL STORE) (Scientific: Epinephrine 1 mg/ml [1: 1000 1:1000]).
            • Dose: 0.01 mg/kg of 1 mg/ml solution (0.01 ml/kg) injected intramuscularly into the mid-anterolateral thigh.
            • Maximum Single Dose: Children <25–30 kg: 0.15–0.3 mg (0.15–0.3 ml).
            • Children ≥30 kg: 0.3–0.5 mg (0.3–0.5 ml).
            Weight-Based Volumes
            • Practical Volume Dosing Table: <10 kg: Exactly 0.01 ml/kg measured via a 1 ml low-dead-space syringe.
            • 10–25 kg: 0.15 ml (0.15 mg).
            • 25–50 kg: 0.3 ml (0.3 mg). >50 kg: 0.5 ml (0.5 mg).
            • Repeat Dosing: If symptoms persist, repeat the dose every 5 to 15 minutes.
            • Most refractory reactions respond to a second dose given within 10 minutes.

            2. Circulatory Shock Resuscitation

            • Formulary Match: SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 500 ML (Teva).
            • Dose: Rapid fluid bolus of 20 ml/kg IV over 5–10 minutes under pressure for refractory hypotension.
            • Anaphylactic shock causes massive transudative fluid shift (>35% of effective circulating volume can extravasate into the extravascular space within 10 minutes).

            3. Secondary/Adjunctive Therapy (Only After Epinephrine has been Given) Bronchospasm/Wheezing Unresponsive to IM Epinephrine:

            • VENTOLIN RESP.SOL. 5MG/MLX20ML (GSK): 2.5–5.0 mg nebulized in 2.5 ml 0.9% NaCl with oxygen.
            Steroid Stabilizer
            • Systemic Glucocorticoids (Secondary Stabilizer): SOLU CORTEF VIAL 100MG (Beit Hanina) (Scientific: Hydrocortisone Sodium Succinate).
            • Dose: 4 mg/kg IV (Max 100 mg) or SOLU MEDROL 40 MG/ML at 1–2 mg/kg IV.
            Antihistamine
            • Antihistamine (Cutaneous Urticaria Control): CETRISAM SYRUP (Sama Pharmaceutical, 100 ml) or HISTAZINE SYRUP 115 ML *(Scientific: Cetirizine 5 mg/5 ml).
            • Dose: 6 months to 2 years: 2.5 mg (2.5 ml) PO.
            • 2 to 5 years: 2.5–5 mg (2.5–5 ml) PO. >6 years: 10 mg (10 ml) PO. (Note: Avoid parenteral Promethazine due to hypotensive and sedating effects that can mimic worsening shock).
            Discharge & Outpatient Transition Regimen

            Mandatory Observation: Observe all anaphylaxis patients in the ER for a minimum of 4 to 8 hours (extended to 12–24 hours if severe shock, required >1 epinephrine dose, or presentation has biphasic risk factors).

            1. Epinephrine Auto-Injector prescription & comprehensive anaphylaxis action plan.

            2. Short-Course Oral Antihistamine (Symptomatic control of itching and hives):

            CETRISAM 10 (Sama Pharmaceutical) [Or CETRISAM SYRUP for children <6 yrs]Discharge Rx · verbatim guide

            Scientific: Cetirizine Dihydrochloride.
            • Sig: - Age 2–5 years: 2.5 ml (2.5 mg) PO once daily for 3 days. - Age >=6 years: 10 mg (1 tab or 10 ml) PO once daily for 3 days.

            3. Optional Short-Course Oral Glucocorticoid:

            PREDNILET 15 MG SYRUP 60 ML (BPC)Discharge Rx · verbatim guide

            Scientific: Prednisolone 15 mg/5 ml.
            Sig: 1 mg/kg/day PO once daily in the morning with food for 2 to 3 days (Max 40 mg/day).
            Red Flags & Safety Warnings
            • Never Sit or Stand an Anaphylaxis Patient Upright: Sudden transition to an upright posture removes peripheral venous return to an underfilled heart, precipitating pulseless electrical activity (PEA) or cardiac arrest ("empty ventricle syndrome").
            • Keep patients flat with legs elevated (unless precluded by severe upper airway obstruction/vomiting).
            • Refractory Anaphylaxis: Patients who fail to respond to 2 doses of IM epinephrine require an immediate continuous IV Epinephrine infusion (0.1–1.0 mcg/kg/min) titrated via infusion pump in an intensive care setting.
            Source: PALMEDICS — 8. PEDIATRIC ANAPHYLAXIS & SEVERE ALLERGIC EMERGENCIES (full verbatim text).
            9. PEDIATRIC ACUTE FEVER, DISTRESS & INFLAMMATORY PAIN 1
            Treat distressAAP · Perrott▾

            9. PEDIATRIC ACUTE FEVER, DISTRESS & INFLAMMATORY PAIN

            paracetamol vs ibuprofen · exact local formulations · aspirin ban

            Background talk — comfort goals & paracetamol vs. ibuprofen

            • Clinical Presentation & Diagnostic Triage — Assessment of Pediatric Pain & Fever: Fever is a physiological adaptive response mediated by pyrogenic cytokines (IL-1 IL-1, IL-6 IL-6, TNF-α TNF-α) driving hypothalamic prostaglandin E2 E 2 (PGE2) production.
            Goal — Comfort, Not Numbers
            • Goal of Antipyresis: The primary endpoint of antipyretic therapy is improving the child's comfort, activity level, and hydration status—not normalizing the temperature curve.
            Pain Scales (FLACC / Wong-Baker)
            • Pain Scales: Use validated metrics including the FLACC score (Face, Legs, Activity, Cry, Consolability) for non-verbal infants and toddlers, and the Wong-Baker FACES Pain Scale for children ≥4 years.
            Paracetamol vs. Ibuprofen
            • Comparative Evidence & Pharmacological Rationale — Paracetamol (Acetaminophen) vs. Ibuprofen Monotherapy — Efficacy Comparison (Perrott et al., Arch Pediatr Adolesc Med meta-analysis): Ibuprofen (10 mg/kg) is slightly more effective than Paracetamol (15 mg/kg) in both antipyretic duration (6–8 hours vs. 4–6 hours) and reduction of moderate-to-severe musculoskeletal, soft tissue, and inflammatory pain.
            Safety Profiles
            • Safety & Toxicological Distinctions: Paracetamol: Acts centrally by inhibiting cyclooxygenase variants and interacting with endogenous cannabinoid/vanilloid pathways.
            • Safe in dehydration and viral infections, with minimal gastric or platelet effects.
            • Primary toxicity is hepatic necrosis from N -acetyl- p -benzoquinone imine (NAPQI) accumulation when glutathione stores are depleted.
            • Ibuprofen: Potent peripheral and central non-selective COX −1/COX −2 COX−1/COX−2 inhibitor.
            • Highly effective for acute inflammation (e.g., otitis media, pharyngitis, fractures).
            Ibuprofen — Contraindications
            • Ibuprofen Contraindications: Contraindicated in dehydration or acute renal impairment because it blocks vasodilatory renal prostaglandins (PGE2, PGI2), which compromises afferent arteriolar blood flow and can precipitate acute tubular necrosis.
            • Also contraindicated in varicella (chickenpox) due to an increased risk of severe necrotizing soft-tissue and streptococcal superinfections.
            Alternating — Don\'t
            • Alternating vs. Combined Antipyretic Therapy: AAP Guidelines advise against routine alternating regimens of paracetamol and ibuprofen due to high caregiver dosing error rates (>50%) that lead to supratherapeutic poisoning.
            • If monotherapy fails to alleviate distress after 3–4 hours, single-agent crossover or carefully supervised alternating regimens may be considered under clear written schedules.
            In-ER & Outpatient Pharmacotherapy — see protocols below

            1. Paracetamol (Acetaminophen) Protocols

              Weight-Based Dose:
              • 15 mg/kg/dose orally every 4 to 6 hours as needed.
              Dosing Limits:
              • Maximum single dose: 1000 mg. Maximum daily dose: 60 mg/kg/day (not to exceed 4000 mg/24 hours).
              Drops (<1 Year)
              • Concentrated Drops (Infants <1 Year): Tailol Concentrated Suspension (Pharmacare Store, 15 ml) or Paramol Infant Drops (Beit Jala, 20 ml) or NOVIMOL TIPTIPOT 15 ML (Syam).
              • Scientific: Paracetamol 100 mg/1 ml. Math: A 6 kg infant requires 6 kg ×15 mg/kg=90 mg=0.9 ml 6 kg×15 mg/kg=90 mg=0.9 ml PO.
              Syrups (1–6 Years)
              • Pediatric Syrups (Ages 1 to 6 Years): MOLPAR 125 mg Syrup (Sama) or TAILOL 125 MG SYRUP (Pharmacare) (Scientific: Paracetamol 125 mg/5 ml).
              • Math: A 10 kg child requires 150 mg=6.0 ml PO.
              Syrups (6–12 Years)
              • High-Concentration Syrups (Ages 6 to 12 Years): ACAMOLI BIG KIDS FRUTI250 SYRUP (Teva, 100 ml) or MOLPAR 250 mg Syrup (Sama) or PARAMOL EXTRA SUSP 250 MG (Beit Jala).
              • Scientific: Paracetamol 250 mg/5 ml (50 mg/ml).
              • Math: A 20 kg child requires 300 mg=6.0 ml PO.
              Suppositories
              • Rectal Suppositories (For Vomiting/Inability to Take Oral Meds): MOLPAR 80 mg 6 Supp (Sama) (Infants 5–6 kg).
              • MOLPAR 150 mg 12 SUPP (Sama) or FEBRAMOL INFANT 150mg (BPC) (Infants 9–12 kg).
              • MOLPAR 250 mg 12 SUPP (Sama) or PARAMOL 300MG child supp (Beit Jala) (Children 16–20 kg).
              Intravenous
              • Intravenous (ER Resuscitation for Severe Pain/Nil Per Os): PARACETAMOL B.BRAUN 10 MG/ML 50 ML/100 ML (MSS) or PARACETAMOL ALTAN 10MG/ML (Medimarket).
              • Dose: Weight <10 kg: 7.5–10 mg/kg IV infused over 15 minutes every 6 hours.
              Weight 10–50 kg:
              • 15 mg/kg IV infused over 15 minutes every 6 hours.

            2. Ibuprofen Protocols

              Weight-Based Dose:
              • 10 mg/kg/dose orally every 6 to 8 hours with meals.
              Dosing Limits:
              • Maximum single dose: 400 mg. Maximum daily dose: 40 mg/kg/day (up to 1200–2400 mg/24 hours).
              Age Restriction:
              • Safe in infants ≥6 months of age.
              Suspensions 100 mg/5 ml
              • Standard Pediatric Suspensions (100 mg/5 ml=2%): ADVIL CHILDREN'S GRAPE FLAVOR (MSS, 120 ml) or IBOO 2% 200 ML SUSP (Teva) or Isofen Suspension (Beit Jala, 100 ml) or Q-FEN SUSPENSION 100 ML (Pharmacare).
              • Scientific: Ibuprofen 100 mg/5 ml (20 mg/ml).
              • Math: A 12 kg child requires 12 kg ×10 mg/kg=120 mg=6.0 ml 12 kg×10 mg/kg=120 mg=6.0 ml PO every 6–8 hours.
              Suspensions 200 mg/5 ml
              • High-Concentration Suspensions (200 mg/5 ml=4%): Ibusama forte Suspension (Sama, 100 ml) or TRUFEN FORTE SUSPENSION (Jepharm, 100 ml) or IBOO 4% for children (Teva, 30 ml).
              • Scientific: Ibuprofen 200 mg/5 ml (40 mg/ml).
              • Math: A 24 kg child requires 240 mg=6.0 ml PO every 6–8 hours (reduces administration volume by 50%).
              Rectal Suppositories:
                Suppositories
                • Nurofen for children suppositories 60mg (MSS) or ULTRAFEN 60 mg Supp. (BPC) (Infants 6–8 kg).
                • Nurofen for children suppositories 125mg (MSS) or ULTRAFEN 125 Supp (BPC) (Children 12.5–15 kg).
              Red Flags & Safety Warnings
              • Aspirin (Acetylsalicylic Acid) Prohibition:
              • Never prescribe aspirin-containing products (ASPIRIN, ACAMOL FOCUS, EXIDOL, SEDAPRIN) to children or adolescents with acute febrile illnesses.
              • Aspirin exposure during active influenza or varicella infection is definitively linked to Reye's Syndrome (microvesicular hepatic fatty metamorphosis accompanied by acute hyperammonemic encephalopathy and high mortality).
              • Nephrotoxicity Warning: Avoid NSAIDs in any pediatric patient with poor oral fluid intake, clinical dehydration, hypotension, preexisting renal compromise, or history of glomerulonephritis.
              Source: PALMEDICS — 9. PEDIATRIC ACUTE FEVER, DISTRESS & INFLAMMATORY PAIN (full verbatim text).
              10. ACUTE VIRAL BRONCHIOLITIS (RSV) IN INFANTS 1
              Supportive — no routine antibioticsAAP 2014▾

              10. ACUTE VIRAL BRONCHIOLITIS (RSV) IN INFANTS

              Suction + oxygen + fluids · trial salbutamol only with documented response

              Background talk — RSV debris, triage & what not to give

              • Pathophysiology: Respiratory syncytial virus (RSV) necrosis of bronchiolar epithelium with intraluminal debris, mucosal edema and air-trapping; peak age 2–8 months, season winter–spring.
              Triage
              • Mild: Feeding well, SpO2 ≥92% on room air, mild tachypnea, no apneas.
              • Moderate: Tachypnea, intercostal retractions, SpO2 90–92%, reduced feeding.
              • Severe: Apnea, grunting, SpO2 <90% on air, poor feeding (<50% of normal), dehydration, exhaustion.
              What NOT to Give Routinely (AAP 2014)
              • No routine salbutamol, systemic corticosteroids, antibiotics, chest physiotherapy or hypertonic saline in the ER; none shortens the illness and each adds harm.
              • Give oxygen only if SpO2 persistently <90%; brief dips during sleep or feeding need observation, not admission alone.
              In-ER Care — see steps below

              1. Airway Clearance & Oxygen

              • Gentle nasal suction before feeds and as needed; bulb or low-pressure wall suction.
              • Formulary Match: SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 100 ML (Teva).
              • Dose: 2–4 ml of 0.9% NaCl via jet nebulizer every 4–6 hours to mobilize secretions.
              • Low-flow oxygen by nasal cannula titrated to keep SpO2 ≥90%; continuous pulse oximetry in moderate–severe cases.

              2. Fluids & Feeding

              • Encourage small frequent breastfeeds or oral rehydration solution; nurse upright 30°.
              • If dehydrated or in shock: 10–20 ml/kg IV bolus of 0.9% NaCl over 10–20 minutes; reassess and repeat to 40–60 ml/kg.
              • Maintenance per Holliday-Segar when the infant cannot feed: first 10 kg 100 ml/kg/day.

              3. Salbutamol Trial ONLY (Documented Response or Stop) + Antipyresis

              • Formulary Match: VENTOLIN RESP.SOL. 5MG/MLX20ML (GSK) or VENTOL RESP. SOL (BPC) (Scientific: Salbutamol 5 mg/ml).
              • Single Trial Dose: Weight <20 kg: 2.5 mg (0.5 ml) in 2.5 ml saline; continue ONLY if tachypnea, retractions or SpO2 objectively improve within 30 minutes — otherwise stop and do not repeat.
              • Antipyresis: ACAMOLI BIG KIDS FRUTI250 SYRUP (Teva, 100 ml) (Scientific: Paracetamol 250 mg/5 ml).
              • Dose: 15 mg/kg PO every 4–6 hours as needed for fever/distress (Max 4 doses/24 hr).
              SODIUM CHLORIDE 0.9% INTRAVENOUS INFUSION BP BAGS 100 ML (Teva)Nebulizer diluent · local formulary
              Scientific: Sodium Chloride 0.9%.
              Sig: 2–4 ml via jet nebulizer every 4–6 hours for secretion mobilization.
              ACAMOLI BIG KIDS FRUTI250 SYRUP (Teva, 100 ml)Discharge Rx · local formulary
              Scientific: Paracetamol 250 mg/5 ml.
              Sig: Give [Calculate: 15 mg/kg] PO every 4 to 6 hours as needed for fever/distress (Max 4 doses/24 hr).
              Red Flags & Safety Warnings
              • Apnea (especially age <2 months), grunting, cyanosis or SpO2 <90% on air: admit; consider high-flow/CPAP and PICU transfer.
              • High-risk infants (premature, chronic lung disease, congenital heart disease, immunodeficiency): admit at a lower threshold.
              • Return immediately for apnea, blue lips, worsening work of breathing, feeding <50% or fewer wet diapers.
              • Do NOT prescribe antibiotics, steroids or cough medicines for uncomplicated bronchiolitis.
              In this protocol — tap to find in store:
              Source: PALMEDICS — 10. ACUTE VIRAL BRONCHIOLITIS (local formulary guidance).
              11. PEDIATRIC URINARY TRACT INFECTION (CYSTITIS & PYELONEPHRITIS) 1
              Culture before antibioticsAAP UTI▾

              11. PEDIATRIC URINARY TRACT INFECTION (CYSTITIS & PYELONEPHRITIS)

              Bag screens, catheter cultures · cephalexin / cefixime / ceftriaxone by age and severity

              Background talk — E. coli, collection & imaging

              • Pathogens: Escherichia coli causes 80–90% of pediatric UTIs; Klebsiella, Proteus and Enterococcus make up most of the rest.
              Urine Collection
              • Bag specimens only screen — a positive bag needs confirmation; catheterized or clean-catch midstream specimens are required for culture.
              • Dipstick leukocyte esterase + nitrites supports UTI; always send culture BEFORE the first antibiotic dose.
              Who Needs Imaging
              • Renal/bladder ultrasound after a first febrile UTI at 2–24 months; VCUG only for recurrent UTI, atypical organisms or abnormal ultrasound — not routine.
              In-ER Care — see steps below

              1. Febrile Infant <2 Months — Admit for IV Therapy

              • Any febrile infant under 2 months with suspected UTI is managed as neonatal sepsis: admit, blood + urine cultures, IV ampicillin + cefotaxime per the sepsis/meningitis protocol — no outpatient oral therapy.

              2. Cystitis — Oral Therapy (7 Days)

                Option A — Cephalexin
                • Formulary Match: CEFOVIT 250MG SUSP (Alwaleed) or CEFALEX 250MG GRAN,100ml (BPC) (Scientific: Cephalexin 250 mg/5 ml).
                • Dose: 50 mg/kg/day PO divided every 8 hours for 7 days.
                • Math Example: 12 kg child × 50 mg/kg = 600 mg/day ÷ 3 = 200 mg = 4.0 ml PO three times daily.
                Option B — Amoxicillin-Clavulanate
                • Formulary Match: ECOCLAV BID 400MG 70 ML SUSP (Pharmacare Store) (Scientific: Amoxicillin 400 mg + Clavulanate 57 mg/5 ml).
                • Dose: 45 mg/kg/day (amoxicillin component) PO divided every 12 hours for 7–10 days with food.
                • Math Example: 15 kg child × 45 mg/kg = 675 mg/day ÷ 2 = 337.5 mg ≈ 4.2 ml PO twice daily (verify per-5-ml strength on the label).

              3. Pyelonephritis — Ceftriaxone Then Oral Step-Down (7–10 Days Total)

              • Formulary Match: SAMIXON 1000 MG IV (Pharmacare Store) or CEFIXON 1G VIAL (BPC) (Scientific: Ceftriaxone Sodium 1 g).
              • Dose: 50–75 mg/kg IV or IM once daily (Max 2000 mg) for the vomiting, dehydrated or toxic child; step down to oral cefixime or cephalexin after 24–48 hours afebrile to complete 7–10 days total.
              • Formulary Match (Oral Step-Down): CEFIX 100 MG D/S 75 ML (Jepharm) (Scientific: Cefixime 100 mg — verify per-5-ml strength on the label).
              • Dose: 8 mg/kg PO once daily (Max 400 mg). Math Example: 15 kg child × 8 mg/kg = 120 mg = 6.0 ml PO once daily (for 100 mg/5 ml suspension).
              CEFOVIT 250MG SUSP (Alwaleed)Discharge Rx · local formulary
              Scientific: Cephalexin 250 mg/5 ml.
              Sig: Give [Calculate: 50 mg/kg/day divided every 8 hours] PO for 7 days.
              CEFIX 100 MG D/S 75 ML (Jepharm)Discharge Rx · local formulary
              Scientific: Cefixime 100 mg (verify per-5-ml strength on the label).
              Sig: Give [Calculate: 8 mg/kg] PO once daily for 7–10 days.
              Red Flags & Safety Warnings
              • Urosepsis (hypotension, poor perfusion), urinary obstruction, dehydration/vomiting or age <2 months: admit for IV therapy.
              • Recurrent febrile UTIs, atypical organism or abnormal ultrasound: refer to nephrology/urology; routine antibiotic prophylaxis is NOT recommended.
              • Uncircumcised infant boys have higher UTI risk — counsel parents; constipation and dysfunctional voiding drive recurrences.
              In this protocol — tap to find in store:
              Source: PALMEDICS — 11. PEDIATRIC URINARY TRACT INFECTION (local formulary guidance).
              12. ACUTE STREPTOCOCCAL PHARYNGITIS (GAS) 1
              10 days prevents rheumatic feverIDSA 2012▾

              12. ACUTE STREPTOCOCCAL PHARYNGITIS (GAS)

              McIsaac score · amoxicillin once daily · penicillin V alternative

              Background talk — GAS vs. virus & why 10 days

              • Epidemiology: Group A Streptococcus causes 20–30% of pharyngitis in school-age children; under age 3 nearly all sore throats are viral — do not test or treat routinely.
              McIsaac Score (1 Point Each)
              • Fever ≥38°C, tonsillar exudate, tender anterior cervical nodes, absence of cough, age 3–14 years (subtract 1 point if age ≥45, not applicable in children). Score 0–1: neither test nor treat; 2–3: rapid antigen test with backup culture; 4–5: test and treat while awaiting culture.
              Why Treat Within 9 Days
              • Starting antibiotics within 9 days of onset prevents acute rheumatic fever; treatment also shortens symptoms by ~1 day and stops contagion after 24 hours of therapy.
              In-ER Prescribing — see steps below

              1. Amoxicillin — First-Line, Once Daily

              • Formulary Match: AMOXICARE 400MG - 70ML SUSP (Pharmacare Company) (Scientific: Amoxicillin 400 mg/5 ml).
              • Dose: 50 mg/kg PO once daily (Max 1000 mg) for 10 full days with food.
              • Math Example: 20 kg child × 50 mg/kg = 1000 mg = 12.5 ml PO once daily for 10 days.

              2. Penicillin V — Alternative

              • Formulary Match: BEPEN V.K 250MG GRAN 100ml (BPC) or PEN-RAFA SUSP. 60ML (Syam) (Scientific: Phenoxymethylpenicillin — verify per-5-ml strength on the label).
              • Dose: Weight <27 kg: 250 mg PO twice daily; weight ≥27 kg: 500 mg PO twice daily — for 10 full days (for 250 mg/5 ml suspension: 5 ml or 10 ml twice daily).

              3. Analgesia + Return Precautions

              • Honey (age ≥1 year), cold fluids and paracetamol 15 mg/kg per the fever/pain protocol; avoid ibuprofen on an empty stomach.
              • Child is contagious until 24 hours of antibiotics completed — keep home from school for the first day.
              • Complete all 10 days even if the throat feels better after 2–3 days; Stopping early risks rheumatic fever.
              AMOXICARE 400MG - 70ML SUSP (Pharmacare Company)Discharge Rx · local formulary
              Scientific: Amoxicillin 400 mg/5 ml.
              Sig: Give [Calculate: 50 mg/kg, max 1000 mg] PO once daily for 10 full days.
              BEPEN V.K 250MG GRAN 100ml (BPC)Discharge Rx · local formulary
              Scientific: Penicillin V Potassium 250 mg (verify per-5-ml strength on the label).
              Sig: <27 kg: 250 mg PO twice daily; ≥27 kg: 500 mg PO twice daily — for 10 full days.
              Red Flags & Safety Warnings
              • Drooling, stridor, trismus or deviated uvula: peritonsillar abscess or epiglottitis — do NOT examine forcefully; refer urgently to ENT.
              • Scarlet fever rash, hematuria/edema 1–3 weeks later (post-streptococcal glomerulonephritis), migratory arthritis or carditis weeks later (rheumatic fever): refer.
              • Carriers with repeated positive swabs but no symptoms do NOT need repeated antibiotics.
              In this protocol — tap to find in store:
              Source: PALMEDICS — 12. ACUTE STREPTOCOCCAL PHARYNGITIS (local formulary guidance).
              13. ACUTE OTITIS EXTERNA (SWIMMER'S EAR) 1
              Topical beats oralAAO-HNS▾

              13. ACUTE OTITIS EXTERNA (SWIMMER'S EAR)

              Ciprofloxacin/hydrocortisone drops · dry ear · wick if swollen shut

              Background talk — canal infection vs. AOM

              • Pathogens: Pseudomonas aeruginosa and Staphylococcus aureus thrive in a warm wet canal after swimming or trauma from cotton swabs and ear candling.
              Telltale Signs
              • Sharp pain when pressing the tragus or pulling the pinna, itching, canal edema and purulent otorrhea; the eardrum itself is normal when visible — unlike acute otitis media where the drum bulges.
              Do NOT Swab or Syringe
              • Never insert cotton swabs and never syringe an actively infected, swollen canal; both worsen edema and risk eardrum injury.
              In-ER Care — see steps below

              1. Topical Antibiotic-Steroid Drops + Wick

              • Formulary Match: FLOXIN-HC OTIC DROPS (Jepharm) (Scientific: Ciprofloxacin 0.2% + Hydrocortisone 1% otic drops).
              • Dose: 3 drops into the affected ear twice daily for 7 days.
              • Technique: Warm the bottle in the hands, lie on the side 3–5 minutes, then press the tragus 4–5 times (tragal pump) to drive drops down the canal.
              • If the canal is swollen shut: place a wick (Pope wick or ribbon gauze) and instill drops onto it; review in 24–48 hours to remove the wick.

              2. Analgesia + Dry-Ear Precautions

              • Paracetamol 15 mg/kg or ibuprofen 10 mg/kg per the fever/pain protocol until pain settles (usually 48–72 hours).
              • Keep the ear completely dry: no swimming for 7–10 days, cotton ball with petroleum jelly at shower time, no ear plugs pushed deep.

              3. When Oral Antibiotics or Referral Are Needed

              • Oral antibiotics (cephalexin per the impetigo protocol) ONLY if cellulitis spreads beyond the canal, or with diabetes, immunocompromise or a perforated drum with systemic features.
              • Ciprofloxacin drops are safe with a perforated eardrum; avoid aminoglycoside drops (ototoxic) if perforation is suspected.
              • Refer urgently: severe nocturnal pain with granulation tissue in a diabetic child (malignant otitis externa), facial weakness, mastoid swelling, or no improvement in 48–72 hours.
              FLOXIN-HC OTIC DROPS (Jepharm)Discharge Rx · local formulary
              Scientific: Ciprofloxacin 0.2% + Hydrocortisone 1%.
              Sig: 3 drops into the affected ear twice daily for 7 days; lie on side 3–5 minutes after each dose.
              Red Flags & Safety Warnings
              • Malignant (necrotizing) otitis externa in diabetic/immunocompromised children: excruciating pain, granulation tissue, cranial nerve signs — emergency ENT referral.
              • Do NOT use oral antibiotics alone for uncomplicated otitis externa — topical therapy delivers 100–1000× higher canal concentrations.
              • Recurrent episodes: check for eczema of the canal, hearing aids or chronic swimming without drying.
              In this protocol — tap to find in store:
              Source: PALMEDICS — 13. ACUTE OTITIS EXTERNA (local formulary guidance).
              14. PEDIATRIC FUNCTIONAL CONSTIPATION & FECAL IMPACTION 1
              Disimpact then maintainNASPGHAN▾

              14. PEDIATRIC FUNCTIONAL CONSTIPATION & FECAL IMPACTION

              PEG 1–1.5 g/kg disimpaction · lactulose backup · toilet training

              Background talk — withholding cycle & red flags

              • Mechanism: A painful stool triggers withholding; retained stool hardens, the rectum stretches and urge fades, and liquid stool leaks around the impaction (encopresis/soiling) — most cases are functional (Rome IV), not disease.
              Red Flags (Not Functional)
              • Delayed meconium beyond 48 hours, ribbon/pellet stools from birth, bilious vomiting with distension, blood without fissure, failure to thrive, spinal hair tuft/dimple or hypothyroidism signs: refer — do NOT just prescribe laxatives.
              PEG Is First-Line (NASPGHAN)
              • Polyethylene glycol beats lactulose for disimpaction success and maintenance adherence, with less cramping and flatulence.
              In-ER Care — see steps below

              1. Disimpaction (3–6 Days)

              • Formulary Match: NORMALAX OTC 240G POWDER (Alram) (Scientific: Polyethylene glycol powder — measure grams with the enclosed scoop per the label).
              • Dose: 1–1.5 g/kg/day PO divided in 2 doses for 3–6 days (Max 100 g/day), dissolved in water or juice, until stools turn to clear watery diarrhea.
              • Math Example: 20 kg child × 1.25 g/kg = 25 g/day ÷ 2 = 12.5 g PO twice daily.

              2. Maintenance + Backups

              • PEG Maintenance: 0.4–0.8 g/kg/day PO once daily for at least 2 months after regular soft stools return. Example: 20 kg child = 8–16 g PO once daily.
              • Formulary Match (Alternative): LACTUVER 66.7% SYRUP (Jepharm) or IMLAX SOLUTION (Beit Jala) (Scientific: Lactulose — verify per-5-ml strength on the label).
              • Lactulose Dose: 1–3 ml/kg/day PO divided every 12 hours. Example: 15 kg child = 15–45 ml/day ÷ 2 = 7.5–22.5 ml PO twice daily.
              • Infants (Rectal Rescue): GLYCERIN CHILD SUPP (Alwaleed) 1 suppository rectally as a single rescue dose.
              • Older Children (Rectal Rescue): FLEET ENEMA SINGLE (Alram) 1 enema rectally as a single rescue dose — never repeat daily without review.

              3. Toilet Training + Follow-Up

              • Sit on the toilet 5 minutes after each meal with a footstool (knees above hips); sticker chart and praise, never punishment for soiling.
              • Daily water, fruits/vegetables and activity; keep a stool diary and review in 2 weeks, then monthly until 1 month past normal pattern.
              NORMALAX OTC 240G POWDER (Alram)Discharge Rx · local formulary
              Scientific: Polyethylene glycol powder.
              Sig: Disimpaction [Calculate: 1–1.5 g/kg/day] PO in 2 doses for 3–6 days (Max 100 g/day); then maintenance [Calculate: 0.4–0.8 g/kg/day] PO once daily for ≥2 months.
              LACTUVER 66.7% SYRUP (Jepharm)Discharge Rx · local formulary
              Scientific: Lactulose (verify per-5-ml strength on the label).
              Sig: Give [Calculate: 1–3 ml/kg/day] PO divided every 12 hours.
              Red Flags & Safety Warnings
              • Bilious vomiting, marked distension or no stool AND no gas: bowel obstruction — emergency surgical referral, no laxatives.
              • Never use mineral oil in infants (aspiration risk) and never repeat enemas daily without medical review (electrolyte shifts).
              • Blood mixed in stool, weight loss or developmental/neurologic signs: investigate before maintenance therapy.
              In this protocol — tap to find in store:
              Source: PALMEDICS — 14. PEDIATRIC FUNCTIONAL CONSTIPATION (local formulary guidance).
              15. IMPETIGO, ECTHYMA & SUPERFICIAL SKIN INFECTION 1
              Mupirocin if limitedIDSA SSTI▾

              15. IMPETIGO, ECTHYMA & SUPERFICIAL SKIN INFECTION

              Honey crusts · mupirocin 3×/day · cephalexin if extensive

              Background talk — Staph/Strep skin & SSSS alarm

              • Pathogens & Forms: Staphylococcus aureus and Streptococcus pyogenes. Non-bullous impetigo: honey-colored crusts on face/limbs; bullous impetigo: fragile blisters from exfoliative toxin; ecthyma: deeper punched-out ulcers with crust.
              SSSS Is an Emergency
              • Staphylococcal scalded skin syndrome (fever + widespread tender redness with sheet-like peeling, Nikolsky sign) needs emergency admission — it is NOT routine impetigo.
              Hygiene First
              • Trim nails, separate towels, wash crusts gently with soap and water twice daily; nasal Staph carriage drives recurrences.
              In-ER Care — see steps below

              1. Limited Lesions — Topical Mupirocin

              • Formulary Match: Mubizeen ointment (Beit Jala) or MUPIROCIN-TEVA 2%15G OINT (Teva) or Bactroban Dermal. (GSK) (Scientific: Mupirocin 2%).
              • Dose: Thin layer to lesions 3 times daily for 5 days after gentle crust removal.

              2. Extensive, Bullous or Ecthyma — Oral Cephalexin

              • Formulary Match: CEFOVIT 250MG SUSP (Alwaleed) or CEFALEX 250MG GRAN,100ml (BPC) (Scientific: Cephalexin 250 mg/5 ml).
              • Dose: 25–50 mg/kg/day PO divided every 8 hours for 7 days.
              • Math Example: 18 kg child × 25 mg/kg = 450 mg/day ÷ 3 = 150 mg = 3.0 ml PO three times daily (up to 300 mg = 6.0 ml per dose at 50 mg/kg/day).

              3. Exclusion + Follow-Up

              • Exclude from school/nursery until 24 hours of antibiotics completed or all lesions are dry/covered; siblings with lesions need same-day review.
              • Review in 48–72 hours; swab failures for culture; decolonize recurrent cases (nasal mupirocin + chlorhexidine washes per local protocol).
              Mubizeen ointment (Beit Jala)Discharge Rx · local formulary
              Scientific: Mupirocin.
              Sig: Thin layer to lesions 3 times daily for 5 days.
              CEFOVIT 250MG SUSP (Alwaleed)Discharge Rx · local formulary
              Scientific: Cephalexin 250 mg/5 ml.
              Sig: Give [Calculate: 25–50 mg/kg/day divided every 8 hours] PO for 7 days.
              Red Flags & Safety Warnings
              • SSSS (fever + tender widespread erythema/desquamation): emergency admission — do NOT manage as outpatient impetigo.
              • Rapid spread, necrosis, severe pain out of proportion or systemic toxicity: necrotizing infection — emergency referral.
              • Edema or dark urine 1–3 weeks later (post-streptococcal glomerulonephritis) or abscess that fluctuates: refer; fluctuant lesions need incision and drainage.
              In this protocol — tap to find in store:
              Source: PALMEDICS — 15. IMPETIGO & SUPERFICIAL SKIN INFECTION (local formulary guidance).
              16. SYSTEMATIC PEDIATRIC FORMULARY QUICK REFERENCE 1
              Dosing tableGuide §10 verbatim▾

              16. SYSTEMATIC PEDIATRIC FORMULARY QUICK REFERENCE

              15 first-line regimens · exact formulations + caps

              Consolidated Dosing & Indication Summary — §10 verbatim

              ComplaintFirst-Line Formulation (Formulary Trade Name)CompositionDosingMax
              Acute Severe AsthmaVENTOLIN RESP.SOL. 5MG/ML + IPRAVENT RESPIRATOR SOL.Salbutamol 5 mg/ml + Ipratropium 0.25 mg/ml<20 kg: 2.5 mg Salb + 250 mcg Ipra
              ≥20 kg: 5 mg Salb + 500 mcg Ipra
              Repeat q20m ×3 doses; then Salbutamol only
              Asthma CorticosteroidPREDNILET 15 MG SYRUP or NOVODEXON SYRUPPrednisolone 15 mg/5 ml or Dexamethasone 0.5 mg/5 mlPrednisolone: 2 mg/kg PO stat
              Dexamethasone: 0.6 mg/kg PO stat
              Prednisolone: 60 mg
              Dexamethasone: 16 mg
              Severe Asthma ResuscitationMAGNESIUM SULFATE KALCEKS 50%Magnesium Sulfate 500 mg/ml50 mg/kg IV in 100 ml 0.9% NaCl over 20–30 minMax: 2000 mg (2 g)
              Severe Croup StridorADRENALINE S.A.L.F 1 MG/MLEpinephrine (L-Adrenaline) 1:10000.5 ml/kg (if <5 kg); 5 ml undiluted (if ≥5 kg) nebulizedMax: 5 mg (5 ml) per neb
              Croup Anti-InflammatoryNOVODEXON SYRUP or DEXA-ALISON 8MG/2MLDexamethasone Sodium Phosphate0.15–0.6 mg/kg PO or IM single doseMax: 16 mg
              Intractable Emesis (AGE)ONSET 4mg TAB or ODNATRON 4mg/2ml AmpOndansetron HCl dihydrateOral: 2 mg (8–15 kg), 4 mg (15–30 kg), 8 mg (>30 kg)
              IV: 0.15 mg/kg
              Oral: 8 mg
              IV: 8 mg
              Severe Dehydration ShockSODIUM CHLORIDE 0.9% 500 MLSodium Chloride 0.9%20 ml/kg IV rapid push/pressure over 10–20 minRepeat 20 ml/kg up to 60 ml/kg
              Neonatal Sepsis (<28 d)PENIBRIN 1 GM VIAL + CEFOTAXIM 1G vialAmpicillin Sodium + Cefotaxime SodiumAmpicillin: 100 mg/kg/dose IV q6h
              Cefotaxime: 50 mg/kg/dose IV q6h
              Age/renal adjusted
              Pediatric Meningitis (>28 d)SAMIXON 1000 MG IV + VANCOAVENIR VIAL 500MGCeftriaxone Sodium + Vancomycin HClCeftriaxone: 100 mg/kg/day IV div q12h
              Vancomycin: 15–20 mg/kg/dose IV q6h
              Ceftriaxone: 4 g/day
              Vancomycin: 1 g/dose
              Outpatient Bacterial CAPAMOXICARE 400 MG SUSP.Amoxicillin 400 mg/5 ml90 mg/kg/day PO divided q12h ×5–7 daysMax: 4000 mg/day
              Resistant AOM / SinusitisAugmentin Syrup ES 600mgAmox 600 mg + Clav 42.9 mg/5 ml (14:1)90 mg/kg/day (amox component) PO div q12hMax: 4000 mg/day
              Active Status EpilepticusMIDAZOLAM KALCEKS 5MG/MLMidazolam 5 mg/ml0.2 mg/kg Intranasal (or IM) statMax: 10 mg
              Refractory Status EpilepticusLevebon 100mg/ml (10x5ml)Levetiracetam 100 mg/ml60 mg/kg IV in 50–100 ml 0.9% NaCl over 10 minMax: 4500 mg
              Pediatric AnaphylaxisADRENALINE S.A.L.F 1 MG/MLEpinephrine (Adrenaline) 1:10000.01 mg/kg (0.01 ml/kg) deep IM into anterolateral thighMax: 0.3 mg (<30 kg); 0.5 mg (≥30 kg)
              Acute Pain / AntipyresisACAMOLI BIG KIDS 250 SYRUP or ADVIL CHILDREN'S GRAPEParacetamol 250 mg/5 ml or Ibuprofen 100 mg/5 mlParacetamol: 15 mg/kg PO q4–6h
              Ibuprofen: 10 mg/kg PO q6–8h
              Paracetamol: 1 g/dose (60 mg/kg/day)
              Ibuprofen: 400 mg/dose (40 mg/kg/day)
              Source: PALMEDICS — 16. SYSTEMATIC PEDIATRIC FORMULARY QUICK REFERENCE (full verbatim table).
              No protocols match your filter.
              Full verbatim text of the PALMEDICS Evidence-Based Pediatric Emergency Pharmacotherapy Guide (16 sections), formulated exclusively with the Palestinian local formulary. Brands verified in stock. Educational quick-reference only — verify against full texts, product labels, local resistance and the individual patient; refer/admit severe, atypical or non-responding cases.
              PALMEDICS · ER Guide (verbatim) · 16 protocols · Adult protocols → · ← Back to formulary